Medeze Group

Medeze Group Inventory

The Inventory of Medeze Group (MEDEZE.BK) as of Nov 4, 2026 is 33.72 M THB. In the previous year, Inventory was 18.00 M THB — a change of 87.31% (higher).

Inventory

33.72 MTHB

YoY

87.31%

Last updated:

Inventory of Medeze Group is 2025 33.72 M THB. Inventory of Medeze Group was 2024 18.00 M THB. It decreases by 87.31% higher compared to the previous year.

The Medeze Group Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2021
16.61 M THB
Jan 1, 2022
15.17 M THB
Jan 1, 2023
12.15 M THB
Jan 1, 2024
18.00 M THB
Jan 1, 2025
33.72 M THB
The Medeze Group Inventory history
YEARInventoryYoY
33.72 MTHB+87.31%
18.00 MTHB+48.15%
12.15 MTHB-19.90%
15.17 MTHB-8.65%
16.61 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medeze Group Stock analysis

What does Medeze Group do? Medeze Group PLC operates as a mesenchymal stem cell bank in Thailand, offering stem cell storage services from umbilical cord tissue and adipose tissue, alongside umbilical cord blood storage. The company provides stem cell analysis, separation, cultivation, and storage services, including immune cell potential testing for Natural killer cells. Its white blood cell potential testing service segment evaluates NK cell performance and count, while the other services segment delivers research, data collection on human cellular activities, and medical laboratory tests. The sales of products segment generates revenue through dietary supplements, cosmetics, and dermo cosmetics. The company's primary customers are individuals seeking stem cell storage for future medical use, as well as those requiring immune cell testing and research services. The stem cell sample collection service segment targets expectant parents and medical institutions for cord blood and tissue storage. The white blood cell potential testing service segment serves healthcare providers and patients interested in NK cell analysis. The sales of products segment appeals to consumers purchasing dietary supplements and cosmetic products. Medeze Group PLC's revenue streams are derived from multiple segments: stem cell storage services, immune cell testing, research and laboratory services, and product sales. The stem cell sample collection and storage services form the core offering, while the white blood cell potential testing and other services provide additional value. Product sales contribute to revenue through the distribution of dietary supplements, cosmetics, and dermo cosmetics, targeting both individual consumers and healthcare-focused markets. Medeze Group is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medeze Group stock

Inventory of Medeze Group is 33.72 M THB in 2025.

Inventory of Medeze Group changed from 18.00 M THB to 33.72 M THB, representing a 87.31% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Medeze Group since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Medeze Group historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Medeze Group

All Key Metrics — Medeze Group